Lowering the stress of inflammatory bowel disease.
Giallourakis
Cosmas
C
Harvard Medical School, Massachusetts General Hospital, Boston, USA.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000209:etiology*; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors* / Q000187:drug effects*; D013312:Stress, Physiological / Q000150:complications* / Q000188:drug therapy*; D000813:Anilides; D006146:Guanidines
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006835:Hydrazones; D020928:Mitogen-Activated Protein Kinases; C097256:semapimod; D000813:Anilides; D006146:Guanidines